NCT01969643 2023-03-07A Safety Study of SGN-LIV1A in Breast Cancer PatientsSeagen Inc.Phase 1 Completed290 enrolled
NCT02000882 2022-02-07STAR Cape+BKM120 MBC With Brain MetUS Oncology ResearchPhase 2 Completed10 enrolled 11 charts
NCT02260531 2021-05-20Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain MetastasesDana-Farber Cancer InstitutePhase 2 Completed36 enrolled 19 charts